Delivery Order SPE2DB22D9309-SPE2DB25FAF29
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for EYLEA HD 8 MG/0.07 ML vials with a ceiling value of $39,625.20. This firm fixed-price delivery order, awarded on September 3, 2025, represents a single supply requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 for EYLEA HD 8 mg/0.07 ml vials on September 3, 2025. The contract, which carries no set-aside designation, calls for delivery by September 24, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain program. This delivery order represents a single purchase of a specialized pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on August 18, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order was issued without a set-aside designation and is set to be completed by September 9, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's facility...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,925.08 on July 29, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This award is funded by the Department of Defense through its Medical Supply Chain function and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,081.24 by the Defense Logistics Agency on August 11, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 2, 2025. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,283.85 by the Defense Logistics Agency on August 29, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 22, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,906.30 by the Defense Logistics Agency on August 4, 2025. The delivery order, contract number 4568997402, is for EYLEA HD 8 mg/0.07 ml vials, with an ultimate completion date of August 25, 2025. This award was made without a set-aside designation, allowing the contractor to compete directly in the federal marketplace....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 firm fixed-price contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product, with a period of performance through June 10, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- SPE2DB22D9309Indefinite Delivery Contract
- SPE2DB22D9309-SPE2DB25FAF29Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility operations worldwide. EYLEA HD is a pharmaceutical product used in ophthalmology for treating retinal conditions. Through its extensive federal contract portfolio with the DLA, DMS Pharmaceutical Group has established itself as a critical supplier in the defense pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide. The company's consistent award activity and established presence in federal procurement markets demonstrate its capability to meet the specialized pharmaceutical distribution requirements of military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 8/1/25 |